Macrophage viability assay

Contact:
Lynn Williams
lynn.williams@kennedy.ox.ac.uk
Rationale

The IL-23/IL-17 axis is of central importance in Psoriatic arthritis (PsA) and Spondyloarthritis (SpA) such as ankylosing spondylitis (AS). Macrophages, dendritic cells, ILCs, and mucosal-associated invariant T cells (MAITs) contribute to elevated IL-23 levels found in the serum, inflamed gut, synovial fluid, entheses, and bone-derived cells, including the marrow. An increased production of pro-inflammatory cytokines in particular IL-23 and TNF-α in response to Toll-like receptor (TLR) agonists, such as lipopolysaccharide (LPS) has been reported to be clinically relevant for AS (1). IL-23 has been shown to drive IL-17 production by pathogenic Th17 cells (CD4) and is implicated in multiple autoimmune and inflammatory diseases including AS.

Aim

To determine any associated toxicity of epigenetic probe set in monocyte-derived macrophages.

Conclusions

None of the probes tested displayed any significant levels of toxicity in all 3 donors.

Experimental Protocol

PBMCs were isolated from whole blood from healthy controls using Histopaque and rested overnight at 37oC 5% CO2. CD14+ monocytes were then isolated by Miltenyi Biotec positive selection kit. Isolated CD14+ were suspended in RPMI 1640 containing 10% FBS and glutamine (R10) at 0.5x 106 / ml cell density and plated out in 60 x 25mm mono plates.

Monocyte differentiation into macrophages:

  1. Monocytes were cultured in R10 medium supplemented GM-CSF (20ng/ml) and cultured for 6 days at 37o Medium (R10) + GM-CSF was re-supplemented at day 3. Cells were harvested at day 6 using 'Accutase' (1 ml per plate for 20 minutes at 37oC, then washed with 10 ml of R10 and collected after centrifugation for 10 min at 300Xg).
  2. Macrophages were plated at 2 x 104 cells / well and left a further 3 days with or without the addition of compounds (1µM final concentration or DMSO control).
  3. At the end of the 3 days, wells were stimulated with 20ng/ml LPS, 20ng/ml IFN-γ and left for 24 hours.
  4. 6 hrs prior to the end of the assay PrestoBlue® 10X reagent was added to microplate wells. Incubate at 37°C for 6 hrs.
  5. Read fluorescence at 590 nm.

PrestoBlue viability assay

Macrophage PB